Navigation Links
GenVault Receives Four Critical U.S. and E.U. Patent Allowances for Key Biosample Management Technologies
Date:5/20/2009

CARLSBAD, Calif., May 20 /PRNewswire/ -- GenVault Corporation is pleased to announce notice of allowance for four key patents in its growing portfolio. U.S. Patent Application #10/005,415, entitled "Automated Biological Sample Archive for Storage, Retrieval & Analysis of a Large Number of Samples" and European Patent Application #02776478.6, entitled "Archive & Analysis System and Method," complement the already-awarded U.S. patent U.S. Patent #7,142,987. Taken together, these allowed and awarded patents grant GenVault broad, exclusive, intellectual property coverage in support of its core business: the development and commercialization of consumables, hardware and software for the acquisition, storage and recovery of biological specimens that have been preserved in the dried solid state, to be used for the building and use as biobanks or biorepositories.

GenVault is also pleased to announce notice of allowance of the first of several key patents in its portfolio which cover novel matrices to stabilize biospecimens in the air-dried state. The allowed claims in "Stable Protein Storage and Stable Nucleic Acid Storage in Recoverable Form," U.S. Patent Application #11/137,806 and European Patent Application #05754240.9, grant GenVault broad, exclusive intellectual property coverage in support of a range of new products based on biospecimen stabilization in engineered sponge and similar materials. The company feels that this new "elastomeric" matrix offers the promise to be a replacement for filter paper, swabs and a number of other matrices for the collection, shipping and storage of biospecimens, especially in the context of public health and personalized medicine.

"GenVault continues to strengthen its leadership position in the emerging field of efficient and cost effective biosample management with an expanding patent portfolio," said David Wellis, CEO, GenVault. "Our growth and value strategy includes firmly establishing GenVault's intellectual property position which enables the company to exclusively market consumables, hardware and software solutions for the efficient transport and banking of biosamples."

About GenVault

GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platforms enable the extraction, preservation, recovery, and distribution of DNA at ambient temperatures. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.

    EDITORIAL CONTACTS:

    Bret Dash, Director of Marketing
    (760) 268-5242
    bdash@genvault.com

Available Topic Expert(s): For information on the listed expert(s), click

appropriate link.

Bret Dash

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87941


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Shane Lyons Joins GenVault Corporation as Vice President of Sales and Marketing
2. GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2
3. GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
4. GenVault to Present at the BIOCOM Investor Conference
5. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
6. GenVault Corporation Launches GenTegra(TM) DNA
7. GenVault Expands Scientific Advisory Board
8. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
9. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
10. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
11. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. ... editing, announced today that Edward Lanphier , Sangamo,s ... on the progress of Sangamo,s ZFP Therapeutic ® ... strategy at 2:40 pm ET on Thursday, February 11, ... Global Healthcare Conference. The conference is being held in ...
(Date:2/4/2016)... 4, 2016 Beike Biotechnology, the ... attended a ceremony in late 2015 to mark their ... in 2016. --> --> ... for Personalized Cell Therapy" was hosted by the Shenzhen ... both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... 4, 2016 --> ... company is pleased to provide the following update on recent ... Over the last 3 months we have significantly increased our ... exceeding $1,000,000. As a result, we have positioned ourselves to ... license agreement and expect that development to continue on schedule. ...
(Date:2/4/2016)... 4, 2016 Sinovac Biotech Ltd. ("Sinovac" or ... of biopharmaceutical products in China , ... of directors received on February 4, 2016 a preliminary ... consortium comprised of PKU V-Ming ( Shanghai ... CICC Qianhai Development ( Shenzhen ) Fund ...
Breaking Biology Technology:
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/28/2016)... (NASDAQ: SYNA ), a leading developer of human interface solutions, ... 2015. --> --> Net ... compared to the comparable quarter last year to $470.5 million. Net ... or $0.93 per diluted share. --> ... fiscal 2016 grew 9 percent over the prior year period to ...
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
Breaking Biology News(10 mins):